Xcout Intel
Applied Therapeutics Inc. competitors & alternatives
The 12 closest competitors and alternatives to Applied Therapeutics Inc. among biotechnology companies — ranked by similarity to what Applied Therapeutics Inc. actually does, not by market-cap band.
Subscribe to see Applied Therapeutics Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Applied Therapeutics Inc.
Applied Therapeutics, Inc. is a biopharmaceutical company headquartered in New York City, focused on developing novel product candidates targeted at disease targets involving enzyme and metabolic pathways.
Applied Therapeutics Inc. at a glance
Applied Therapeutics Inc. is a biotechnology company headquartered in United States. Its most recent funding round raised $100M in February 2024.
Applied Therapeutics Inc. funding rounds
The 6 most recent:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $100M | — | |
| SEC Form D filing | $30M | — | |
| SEC Form D filing | $20M | — | |
| SEC Form D filing | $27.2M | — | |
| SEC Form D filing | $6M | — | |
| SEC Form D filing | $6.1M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Recent Applied Therapeutics Inc. news
Top 12 Applied Therapeutics Inc. competitors
Ranked by semantic similarity — how close each company is to Applied Therapeutics Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotech
Amicus Therapeutics, Inc. is an American biopharmaceutical company focused on discovering and delivering advanced therapies for rare diseases. The company is publicly traded on Nasdaq and maintains its global corporate headquarters in Princeton, New Jersey.
Biotech
Ultragenyx Pharmaceutical Inc. is an American biopharmaceutical company involved in the research and development of novel products for treatment of rare and ultra-rare genetic diseases for which there are typically no approved treatments and high unmet medical need. The company works with multiple drug modalities including biologics, small molecule, gene therapies, and ASO and mRNAs in the disease categories of bone, endocrine, metabolic, muscle and CNS diseases.
Similar biotechnology company
Travere Therapeutics is a biopharmaceutical company headquartered in San Diego, California, focused on identifying, developing, and delivering life-changing therapies for people living with rare diseases.
Similar biotechnology company
OrsoBio, Inc. is a privately held, clinical-stage biopharmaceutical company dedicated to developing therapies to treat severe metabolic disorders.
Similar biotechnology company
Ambros Therapeutics is a clinical-stage biotechnology company headquartered in Irvine, California, focused on the development of innovative therapeutics.
Similar biotechnology company
Amicus Therapeutics, a subsidiary of BioMarin Pharmaceutical Inc., is a biotechnology company that researches and delivers medicines for individuals living with genetically defined rare diseases. The company provides patient advocacy and support services alongside its clinical development pipeline.
Similar biotechnology company
Applied Biological Laboratories Inc. is a privately held biotechnology company founded in 2016 and headquartered in New York, New York, dedicated to developing specialized health and biological products.
Similar biotechnology company
Autobahn Therapeutics, Inc. is a privately held biopharmaceutical company with its corporate office and headquarters located in San Diego, California, focused on restoring hope for patients.
Biotech
Orchard Therapeutics plc is a biopharmaceutical company with operations including a U.S. headquarters located in Boston, Massachusetts.
Similar biotechnology company
Aurora Therapeutics is a biotechnology research company headquartered in Cambridge, Massachusetts. The firm focuses on advanced biomedical research and therapeutic development within the life sciences sector.
Similar biotechnology company
Atrium Therapeutics, Inc. is a biopharmaceutical company dedicated to revolutionizing the treatment of cardiomyopathies by delivering innovative ribonucleic acid (RNA) therapeutics directly to the heart. Their development-stage portfolio currently includes ATR 1072, a siRNA-based therapy targeting the PRKAG2 gene for the treatment of PRKAG2 syndrome, and ATR 1086, another siRNA therapy aimed at the PLN gene to address PLN cardiomyopathy. The company is also actively developing a wider range of pipeline candidates designed to combat various genetic and cardiac diseases. Founded in 2025, Atrium Therapeutics is based in San Diego, California.
Similar biotechnology company
Aileron Therapeutics, Inc. is a clinical-stage biopharmaceutical company with principal executive offices located in Cambridge, Massachusetts. The company went public through a reverse merger and is involved in therapeutic acquisitions and development.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Applied Therapeutics Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Applied Therapeutics Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →